Flonase is a medication whose active ingredient is fluticasone propionate. It is also known by alternative names like Flixonase and Nasofan. This medication is used to relieve nasal congestion, sneezing, and runny or itchy nose caused by allergies.
You can expect to pay between £23.12 and £29.56 for Flonase per nasal sprays. Prices vary with the packaging size and active ingredient quantity (1 or 10 mcg).
Flonase contains the active ingredient fluticasone propionate, a corticosteroid that reduces inflammation and suppresses immune responses. It is formulated for nasal administration to target the affected nasal passages directly.
Flonase is indicated for the relief of symptoms associated with allergic rhinitis and non-allergic rhinitis. These symptoms may include nasal congestion, sneezing, runny nose, and itchy or watery eyes.
The recommended dosage for adults and children over 12 years is two sprays per nostril once a day. For children aged 4 to 11 years, the recommended dose is one spray per nostril once daily. Do not exceed these recommended dosages.
Before first use, prime the spray by shaking and releasing into the air until a fine mist appears. To administer, shake the bottle, gently blow your nose, insert the nozzle into a nostril, and close the other nostril. Spray while gently inhaling and repeat for the other nostril.
Store Flonase at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Keep the cap tightly closed when not in use. Do not store in the bathroom. Keep out of reach of children.
Common side effects of Flonase include headache, nosebleeds, and burning or irritation inside the nose. These side effects are usually mild and may diminish over time with continued use of the medication.
Though rare, serious side effects such as severe nosebleeds, nasal ulcers, or vision problems may occur. Contact a healthcare provider immediately if these symptoms develop. Discontinue use if severe side effects are experienced.
Fluticasone propionate may interact with other medications, including other corticosteroids and certain antifungal and antiviral medicines. Provide a complete list of your current medications to your healthcare provider to avoid potential drug interactions.
Do not use Flonase if you have a known hypersensitivity to fluticasone propionate or any of the other ingredients. Use in patients with existing nasal infections or ulcerations should be closely monitored by a healthcare provider.
The safety of Flonase during pregnancy has not been fully established. Use only if the potential benefits justify the potential risks to the fetus. Consult your healthcare provider if you are pregnant or planning to become pregnant.
It is unknown whether fluticasone propionate is excreted in human breast milk. Exercise caution when administering to nursing mothers. Discuss risks and benefits with a healthcare provider if you are breastfeeding.
Safety and effectiveness have been established in children aged 4 and older. Usage in children under 4 years of age is not recommended. Monitor growth in pediatric patients undergoing prolonged treatment with Flonase.
There have been no significant differences observed in responses between elderly and younger subjects. Nevertheless, a greater sensitivity of some older individuals cannot be ruled out. Adjust dosage if necessary based on clinical response.
Patients with hepatic or renal impairment should use Flonase with caution. Since the drug is metabolized in the liver and excreted by the kidneys, dose adjustments may be required. Consult a healthcare provider for individual assessment.
Fluticasone propionate works by inhibiting multiple cell types and mediators, including histamine, prostaglandins, and leukotrienes, involved in inflammatory responses. This results in reduced inflammation and symptom relief.
Upon nasal administration, the systemic bioavailability of fluticasone propionate is minimal due to its extensive first-pass metabolism in the liver and low plasma concentrations. The drug has a half-life of approximately 7.8 hours.
Advise patients on proper administration techniques. Remind them to shake the bottle before use, maintain regular dosing even if symptoms improve, and not to exceed the recommended dosage. Encourage reporting of any adverse effects.
Patients should not abruptly discontinue Flonase if used for extended periods. Gradual dose tapering is recommended to prevent possible withdrawal symptoms. Consult a healthcare provider for appropriate discontinuation guidance.
Flonase is available as a nasal spray in a plastic bottle with a metered pump, delivering 50 mcg of fluticasone propionate per spray. Each bottle contains a specified number of doses, commonly available in 60 or 120 spray counts.
Check the expiration date on the bottle before use. Do not use the medication past its expiration date. Dispose of the bottle per local regulations once the labeled number of doses is depleted or the product has expired.
Clinical trials have demonstrated Flonase’s effectiveness in reducing nasal inflammation and improving quality of life in patients with allergic rhinitis. Ongoing studies focus on expanding potential uses and minimizing side effects.
Flonase is included in many insurance formularies due to its established efficacy and safety profile. Verify coverage with your insurance plan, which may differ based on specific policies and regional regulations.